Tony Elumelu’s UBA commits to attracting investments in ECOWAS mining sector
The pledge was reaffirmed at the fourth ECOWAS Mining and Petroleum Forum in Cotonou, Benin.
Skip to content
The pledge was reaffirmed at the fourth ECOWAS Mining and Petroleum Forum in Cotonou, Benin.
The incident occurred on Saturday, February 24, impacting the facilities of Port and Cargo Handling Services Limited, a key subsidiary of the conglomerate.
Amusan’s consortium aims to create Africa’s first live entertainment hub, The Arena.
At the Guyana Energy Conference, Tinubu emphasized the imperative of fostering conducive environments for the oil and gas industry’s growth.
Elumelu’s influence extends beyond his roles at UBA, where he serves as chairman, and other entities like Transnational Corporation of Nigeria Plc and Heirs Holdings.
The announcement, made by the board of directors 24 hours after confirming Wigwe’s demise, is contingent upon the approval of the Central Bank of Nigeria.
Afolabi emphasized the consortium’s commitment to leveraging its track record of success in revitalizing enterprises for growth and profitability.
The surge in revenue is linked to the heightened sales of ethical products, including infusions, capsules, and tablets.
Elumelu, through his investment firm HH Capital, holds a commanding 29.5-percent stake in Transcorp, owning 11,990,957,350 ordinary shares.
Iwosan Investments is a leading healthcare investment firm committed to transforming and improving Nigeria’s healthcare landscape.
Notably, Waltersmith Group, led by Nigerian businessman Abdulrazaq Isa, brings extensive experience in oil exploration and production.
Onwuka, the CFO of Seplat Energy, experienced a substantial 7.78-percent increase in his 2022 compensation, reaching $1.55 million.
Babatunde Ajayi, the head of SME Banking at UBA, spoke about the initiative during the Nigerian Canadian Business Association Business 2023 Roundtable held in Lagos.
Custodian Investment surges 10 percent on NGX as market capitalization tops $55 million.
Peterside is a key figure in the Nigerian banking industry.
Ayebae, a banker turned accomplished industrialist, owns a 33.1-percent stake in the pharmaceutical company, which translates to 759,643,749 ordinary shares.